The role of atrial natriuretic peptide (ANP) in chronic liver disease
Author:
- 1 January 1993
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 58 (3) , 381-390
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Disposal of atrial natriuretic factor (ANF99-126) in patients with cirrhosis: Effect of beta-adrenergic blockadeScandinavian Journal of Clinical and Laboratory Investigation, 1993
- Renal sodium retention during upright posture in preascitic cirrhosisGastroenterology, 1993
- Variability of Atrial Natriuretic Peptide Plasma Levels in Ascitic Cirrhotics: Pathophysiological and Clinical ImplicationsHepatology, 1992
- The Hemodynamic Status of Preascitic Cirrhosis: An Evaluation Under Steady–State Conditions and After Postural ChangeHepatology, 1992
- Renal Effects in Cirrhotic Patients With Avid Sodium Retention of Atrial Natriuretic Factor Injection During Norepinephrine InfusionHepatology, 1992
- Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosisJournal of Hepatology, 1992
- Blunted natriuretic response and low blood pressure after atrial natriuretic factor in early cirrhosisHepatology, 1989
- A membrane form of guanylate cyclase is an atrial natriuretic peptide receptorNature, 1989
- The Heart as an Endocrine GlandScientific American, 1986
- Physiologic regulation of atrial natriuretic peptide receptors in rat renal glomeruli.Journal of Clinical Investigation, 1985